Joyce Freidly
Physician Assistant · Baltimore, MDNPI 1457421588
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,192 of the $10,452 with a category attached, or 68.8%. 41 manufacturers reported payments, led by Accord Healthcare, Inc. at 31.3% of the total. Reporting peaked in 2024 at $4,793 and has fallen 63.4% since, to $1,756 in 2025. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $36.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Accord Healthcare, Inc.$3K
- Johnson & Johnson$1K
- Bayer$776
- AbbVie$598
- Astellas Pharma US Inc$459
- Sumitomo Pharma America, Inc.$373
- plus $4K from 35 others
What the payments were for
- Speaking & faculty fees$1,68716%
- Travel & lodging$1,27912%
- Food & beverage$7,19269%
- Education$2943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Accord Healthcare, Inc. | 12 | $3,275 |
| Johnson & Johnson | 42 | $1,253 |
| Bayer | 31 | $776 |
| AbbVie | 27 | $598 |
| Astellas Pharma US Inc | 19 | $459 |
| Sumitomo Pharma America, Inc. | 12 | $373 |
| Dendreon Pharmaceuticals LLC | 11 | $368 |
| Medtronic | 8 | $322 |
| Pfizer | 9 | $227 |
| Endo Pharmaceuticals Inc. | 8 | $226 |
| AstraZeneca | 6 | $206 |
| Teleflex LLC | 5 | $190 |
| Olympus America Inc. | 9 | $188 |
| Novartis | 8 | $188 |
| Amgen | 8 | $161 |
| Tolmar, Inc. | 7 | $160 |
| Ferring Pharmaceuticals Inc. | 4 | $152 |
| Progenics Pharmaceuticals, Inc. | 7 | $151 |
| Merck | 8 | $144 |
| Janssen Scientific Affairs, LLC | 3 | $118 |
| Tempus AI, Inc | 4 | $96 |
| Myovant Sciences Inc. | 5 | $85 |
| Tolmar Pharmaceuticals, Inc. | 4 | $85 |
| Caris MPI, Inc. | 3 | $82 |
| Urovant Sciences Inc | 3 | $70 |
| 180 Medical, Inc. | 2 | $49 |
| Endo USA, Inc. | 3 | $49 |
| Foundation Medicine, Inc. | 2 | $45 |
| Bioprotect Medical, Inc. | 2 | $45 |
| Boston Scientific | 2 | $39 |
| Abbott | 2 | $34 |
| Myriad Genetic Laboratories, Inc. | 2 | $34 |
| Telix Pharmaceuticals | 1 | $28 |
| Urogen Pharma, Inc. | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Immunitybio, Inc. | 1 | $25 |
| Mission Pharmacal Company | 1 | $21 |
| Vertex | 1 | $21 |
| Clovis Oncology, Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $20 |
| Blue Earth Diagnostics | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,452 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 23 | $334,457 |
| NubeqaDarolutamide | 12 | $163,215 |
| Abiraterone Acetate | 17 | $15,577 |
| MyrbetriqMirabegron | 18 | $11,660 |
| Tamsulosin Hcl | 24 | $781 |
| Prednisone | 42 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $459 | $346,11741 claims |
| BayerNubeqa | $776 | $163,21512 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $118 | $15,57717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Baltimore
- Kara CossisBaltimore$177K
- Melissa BearekmanBaltimore$81K
- Praveena GadamBaltimore$24K
- James ShafferBaltimore$12K
- Maria RosenbergBaltimore$10K
- Thomas PetryBaltimore$10K
- Melanie GreenwayBaltimore$10K
- Margaret JoyceTowson$220K
- Garland JamesSilver Spring$86K
- Brittany YerkesSalisbury$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.